French biotech company Global Bioenergies and German cars manufacturer Audi signed a new agreement focused on the implementation of residue usage, preparation of a path to commercialization and engine testing of new blends. Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program.
French industrial biotech company Global Bioenergies and German carmaker Audi reached a key milestone in their multi-year agreement: renewable gasoline components were produced and shipped to Audi. Using its Leuna Demo plant, Global Bioenergies has produced high-purity renewable isobutene, which was further converted by the Fraunhofer Institute into high-performance gasoline additives including isooctane, ETBE and isododecane. These e-fuels will be used in engine testing by Audi, in complement to those already performed by Global Bioenergies.
Clariant, a Swiss leader in specialty chemicals, and French industrial biotech company Global Bioenergies last Tuesday announced the development of a new bio-based polymer for cosmetic creams and lotions, which is derived from renewable isobutene.
The demo plant of French company Global Bioenergies, located at the Leuna refinery site, has successfully operated its entire technical process: fermentation, purification, and filling station. The first bottle containing renewable isobutene has been filled.
Global Bioenergies finalized the acquisition of Syngip B.V. at the close of its extraordinary shareholders’ meeting last Thursday. Established in the Netherlands since 2014, Syngip develops a process to convert gaseous carbon sources into light olefins. Its process is based on a proprietary micro-organism capable of metabolising carbon dioxide (CO2) and carbon monoxide (CO) found in a wide range of low-cost and abundant streams, such as the industrial waste emissions of steel mills.
Global Bioenergies expands in the Netherlands. The French biotech company led by Marc Delcourt signed a contribution agreement with the shareholders of Syngip B.V. to transfer all Syngip shares to Global Bioenergies S.A. The transaction’s completion remains subject to the fulfilment of several suspensive conditions including approval by the shareholders of Global Bioenergies.
Global Bioenergies, the French biotech company that is developing a process to convert renewable resources into hydrocarbons through fermentation, announced yesterday that the construction of its demo plant, started mid-2015, is completed.
Global Bioenergies and Clariant announced yesterday the first isobutene production from a wheat straw hydrolysate, in the industrial pilot of Pomacle Bazancourt, France. This is the result of a collaboration initiated more than 18 months ago, and has been made possible by combining Clariant’s proprietary process, allowing for the conversion of agricultural residues into sugar-rich hydrolysates, with Global Bioenergies’ proprietary process for the production of isobutene from various industrial-grade sugars.
Global Bioenergies, Preem, Sekab and Sveaskog yesterday announced having joined forces to develop a high-performance fuel entirely based on forest resources. The consortium has signed a collaboration agreement to carry out a conceptual scope study for a first plant in Sweden. This work will be carried out as part of the “Bio-Based Gasoline Project” with support from the Swedish Energy Agency.
IBN-One, a subsidiary of Global Bioenergies and Cristal Union, yesterday announced it has awarded the first engineering contract for its bio-isobutene plant to Technip and IPSB. Following a consultation process by IBN-One in spring 2016, the initial engineering work contract has been awarded to a consortium that includes Technip, a global leader in engineering for the energy, petrochemical and chemical industries, and IPSB, an engineering firm specialising in sugar and biotechnologies. This first front-end engineering design (FEED) phase will run for 12 months and precedes the detailed engineering studies for the plant’s construction.